Glutamate signaling may orchestrate oligodendrocyte precursor cell (OPC) development and myelin regeneration through the activation of glutamate receptors at OPC-neuron synapses. D-Aspartate is a D-amino acid exerting modulatory actions at glutamatergic synapses. Chronic administration of D-Aspartate has been proposed as therapeutic treatment in diseases related to myelin dysfunction and NMDA receptors hypofunction, including schizophrenia and cognitive deficits. Here, we show, by using an in vivo remyelination model, that administration of D-Aspartate during remyelination improved motor coordination, accelerated myelin recovery, and significantly increased the number of small-diameter myelinated axons. Chronically administered during demyelination, D-Aspartate also attenuated myelin loss and inflammation. Interestingly, D-Aspartate exposure stimulated OPC maturation and accelerated developmental myelination in organotypic cerebellar slices. D-Aspartate promoting effects on OPC maturation involved the activation of glutamate transporters, AMPA and NMDA receptors, and the Na+/Ca2+ exchanger NCX3. While blocking NMDA or NCX3 significantly prevented D-Aspartate-induced [Ca2+]i oscillations, blocking AMPA and glutamate transporters prevented both the initial and oscillatory [Ca2+]i response as well as D-Aspartate-induced inward currents in OPC Our findings reveal that D-Aspartate treatment may represent a novel strategy for promoting myelin recovery.

D-Aspartate treatment attenuates myelin damage and stimulates myelin repair / de Rosa, Valeria; Secondo, Agnese; Pannaccione, Anna; Ciccone, Roselia; Formisano, Luigi; Guida, Natascia; Crispino, Roberta; Fico, Annalisa; Polishchuk, Roman; D'Aniello, Antimo; Annunziato, Lucio; Boscia, Francesca. - In: EMBO MOLECULAR MEDICINE. - ISSN 1757-4676. - 11:1(2019), p. e9278. [10.15252/emmm.201809278]

D-Aspartate treatment attenuates myelin damage and stimulates myelin repair

de Rosa, Valeria;Secondo, Agnese;Pannaccione, Anna;Ciccone, Roselia;Formisano, Luigi;Guida, Natascia;FICO, ANNALISA;Annunziato, Lucio;Boscia, Francesca
2019

Abstract

Glutamate signaling may orchestrate oligodendrocyte precursor cell (OPC) development and myelin regeneration through the activation of glutamate receptors at OPC-neuron synapses. D-Aspartate is a D-amino acid exerting modulatory actions at glutamatergic synapses. Chronic administration of D-Aspartate has been proposed as therapeutic treatment in diseases related to myelin dysfunction and NMDA receptors hypofunction, including schizophrenia and cognitive deficits. Here, we show, by using an in vivo remyelination model, that administration of D-Aspartate during remyelination improved motor coordination, accelerated myelin recovery, and significantly increased the number of small-diameter myelinated axons. Chronically administered during demyelination, D-Aspartate also attenuated myelin loss and inflammation. Interestingly, D-Aspartate exposure stimulated OPC maturation and accelerated developmental myelination in organotypic cerebellar slices. D-Aspartate promoting effects on OPC maturation involved the activation of glutamate transporters, AMPA and NMDA receptors, and the Na+/Ca2+ exchanger NCX3. While blocking NMDA or NCX3 significantly prevented D-Aspartate-induced [Ca2+]i oscillations, blocking AMPA and glutamate transporters prevented both the initial and oscillatory [Ca2+]i response as well as D-Aspartate-induced inward currents in OPC Our findings reveal that D-Aspartate treatment may represent a novel strategy for promoting myelin recovery.
2019
D-Aspartate treatment attenuates myelin damage and stimulates myelin repair / de Rosa, Valeria; Secondo, Agnese; Pannaccione, Anna; Ciccone, Roselia; Formisano, Luigi; Guida, Natascia; Crispino, Roberta; Fico, Annalisa; Polishchuk, Roman; D'Aniello, Antimo; Annunziato, Lucio; Boscia, Francesca. - In: EMBO MOLECULAR MEDICINE. - ISSN 1757-4676. - 11:1(2019), p. e9278. [10.15252/emmm.201809278]
File in questo prodotto:
File Dimensione Formato  
embo boscia.pdf

solo utenti autorizzati

Licenza: Accesso privato/ristretto
Dimensione 4.89 MB
Formato Adobe PDF
4.89 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/726296
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 43
  • ???jsp.display-item.citation.isi??? 43
social impact